Follow Me

Oncology News Articles

Current Articles | RSS Feed RSS Feed

Focus on Bone Cancer - Best of MDLinx Oncology

  
  
  
  
  

MDLinx Focus on Bone

A Best of Oncology Report
MDLinx.com

Top New Bone Articles

Ranked, sorted, and summarized by MDLinx editors from the latest literature

This month's best articles from 153 contributor journals

Prostate–specific membrane antigen: a new potential prognostic marker of osteosarcoma

Medical Oncology

 

Survival from high–grade localised extremity osteosarcoma

Annals of Oncology

 

Bone Metastases: Assessment of Therapeutic Response through Radiological and Nuclear Medicine Imaging Modalities

Clinical Oncology

 

High–throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide–3–kinase and other oncogenes

Cancer

 

Bone Metastasis From Thyroid Cancer Diagnosed by I–131 Whole–Body Scan Without Identifiable Lesion in the Thyroid

Clinical Nuclear Medicine

 

Effect of Ibandronate on Disseminated Tumor Cells in the Bone Marrow of Patients with Primary Breast Cancer: A Pilot Study

Anticancer Research

 

Top Read Articles in Oncology This Month

1. Adjuvant gemcitabine versus Neoadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable Pancreatic Cancer: A randomized multicenter phase III study (NEOPAC study)
BMC Cancer

2. Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first–line treatment for patients with ovarian cancer: The Mito–2 Randomized Phase III Trial
Journal of Clinical Oncology

3. Phase II study of cetuximab as first–line single–drug therapy in patients with unresectable squamous cell carcinoma of the skin
Journal of Clinical Oncology

4. Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle–invasive bladder cancer submitted to radical cystectomy: An Italian, multicenter, randomized phase III trial
Annals of Oncology

5. A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
Cancer Chemotherapy and Pharmacology

6. KRAS mutation in metastatic pancreatic ductal adenocarcinoma: Results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first–line therapy
Oncology (Karger)

7. Novel Therapeutic Targets in Non–small Cell Lung Cancer
Journal of Thoracic Oncology

>>See the rest of this Month's Top Read